News and Events

  • Extended half-life (EHL) testing for FVIII and FIX therapies

    Posted: November 13, 2024

    David McGlasson The complexities of testing for hemophilia A and B are vast. This Clot Club post serves as an overview of what the laboratory must consider when testing for new EHL products.   When comparing different methods used to determine FVIII and FIX activity, the testing laboratory should evaluate the calibrators used, individual kit…

    Read More

  • The Future of Thrombin Generation Testing

    Posted: November 11, 2024

    It’s Not Just Support. It’s Solutions. The Future of Thrombin Generation Testing Capture prothrombotic changes with global coagulation assays and expand your testing capabilities.  Ceveron® TGA Kits Automated, standardized thrombin generation assay Designed for use on the Ceveron® s100 (Item 9822210) coagulation analyzer Suitable for studies investigating effects of novel therapies Trigger reagent options with optimized Tissue Factor and Phospholipid…

    Read More

  • Connect with DiaPharma – see where we’ll be!

    Posted: September 12, 2024

    It’s Not Just Support. It’s Solutions. VISIT DIAPHARMA AT THESE UPCOMING EVENTS! Connect with DiaPharma to discuss all the latest in hemostasis and liver disease. Interested in learning more about the cytokeratin 18 (CK18) biomarker assays, M30® Apoptosense and M65 ELISA®, for MASH, ALD/AH, DILI , or any of our other cutting edge products? Make…

    Read More

  • Connect with DiaPharma – see where we’ll be!

    Posted: September 11, 2024

    It’s Not Just Support. It’s Solutions. VISIT DIAPHARMA AT THESE UPCOMING EVENTS! Connect with DiaPharma to discuss all the latest in hemostasis and liver disease. Interested in learning more about the Ceveron s100*, the FDA-cleared T-TAS 01, Technozym ADAMTS13 Activity ELISA for IVD use, M30® Apoptosense ELISA for liver damage, or any of our other…

    Read More

  • Discover the T-TAS 01 – the way to measure physiological total platelet function

    Posted: August 26, 2024

    It’s Not Just Support. It’s Solutions. Why Consider the T-TAS 01 for Total Platelet Function Measurement? It’s Not Just Support. It’s Solutions. Over 25 years of scientific expertise, just a call or click away. DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069 Technical Support: 1.800.447.3846 ML-08-00059Rev01

    Read More

  • You’re Invited to an Online Seminar: T-TAS® 01: Ex vivo measurement of thrombus formation with a simple flow chamber system

    Posted: August 22, 2024

    It’s Not Just Support. It’s Solutions. T-TAS 01®: ex vivo measurement of thrombus formation with a simple flow chamber system We invite you to an online seminar: T-TAS® 01: ex vivo measurement of thrombus formation with a simple flow chamber system This online seminar provides the fundamental explanations for T-TAS (Total Thrombus-formation Analysis System) including…

    Read More

  • One Week in Bangkok: Reflections on ISTH 2024

    Posted: July 11, 2024

    It’s Not Just Support. It’s Solutions. One Week in Bangkok: Reflections on ISTH 2024 Our Scientific Director, Jennifer J. Kiblinger, and Director of Commercial Operations, Gloria Sukes O’Neill, traveled to Bangkok for the The International Society on Thrombosis and Haemostasis (ISTH) 2024 Congress in June to hear from the world’s leading minds in thrombosis and…

    Read More

  • One Week in Bangkok – Thoughts on ISTH 2024

    Posted: July 10, 2024

    Jennifer J. Kiblinger Scientific Director First, I need to comment how amazing the people of Thailand were. This introvert was a bit worried about going to such a crowded city, but everyone was so hospitable. At the hotel, at the convention center, on the public transit. Those of you who stayed to the end perhaps…

    Read More

  • View the Webinar Recording of Breaking Barriers: The Evolution of ADAMTS13 Testing

    Posted: June 13, 2024

    It’s Not Just Support. It’s Solutions. View the Webinar Recording Breaking Barriers: The Evolution of ADAMTS13 Testing Everyone loves a good historical perspective talk! Dr. Gary Moore really delivers one here about TTP and ADAMTS13 activity, with a good bit of technology comparison to boot. If you missed the webinar, no worries. You can view…

    Read More

  • Detect Beta Cell Dysfunction precisely with TECO Intact Proinsulin

    Posted: June 12, 2024

    It’s Not Just Support. It’s Solutions. Exploring Unmet Needs in Islet Cell Transplantation and Stem Cell-Derived Islet Research DiaPharma’s Dr. Abi Kasberg headed to Florence for the 2024 Advanced Technologies & Treatments for Diabetes (ATTD) conference to learn more about the utility of intact proinsulin as a biomarker in diabetes and how new drugs in…

    Read More

  • Register Today! Breaking Barriers: The Evolution of ADAMTS13 Testing

    Posted: June 4, 2024

    It’s Not Just Support. It’s Solutions. Complimentary Webinar Breaking Barriers: The Evolution of ADAMTS13 Testing Thursday, June 6 1:00 PM EDT Please join DiaPharma, our partner Technoclone for a webinar presented by Professor Gary Moore, about TTP, TMAs, and the “value add” of laboratory testing for ADAMTS13 activity. We will discuss the significance of ADAMTS13,…

    Read More

  • T-TAS 01 in Thailand! Join us in Bangkok

    Posted: May 30, 2024

    It’s Not Just Support. It’s Solutions. T-TAS 01 in Thailand! DiaPharma is excited to share that ZACROS, manufacturer of the T-TAS 01, will be exhibiting at ISTH 2024 in Booth #1609. During the exhibition, there will be an opportunity to see T-TAS 01 demonstrations and discuss applications for the clinical laboratory. We invite DiaPharma customers…

    Read More

  • Webinar Alert! Breaking Barriers: The Evolution of ADAMTS13 Testing

    Posted: May 23, 2024

    It’s Not Just Support. It’s Solutions. Complimentary Webinar Breaking Barriers: The Evolution of ADAMTS13 Testing Thursday, June 6 1:00 PM EDT Please join DiaPharma, our partner Technoclone for a webinar presented by Professor Gary Moore, about TTP, TMAs, and the “value add” of laboratory testing for ADAMTS13 activity. We will discuss the significance of ADAMTS13,…

    Read More

  • CONTINUING CONTROVERSY ON USING A NORMALIZATION CALCULATION ON DILUTE RUSSELL VIPER TIME

    Posted: May 9, 2024

    David L. McGlasson, MS, MLS(ASCP) Several years ago, I was the lead author of a manuscript titled: Comparison of six dilute Russell Viper Venom Time (DRVVT) lupus anticoagulant (LA) screen/confirm assay kits.1 The purpose of the protocol was to see if using normalized ratio gave our laboratory any better inter-method consistency when performing the DRVVT…

    Read More

  • Complimentary Webinar: ATLAS PST: A New Dimension in Platelet Function

    Posted: May 8, 2024

    It’s Not Just Support. It’s Solutions. Complimentary Webinar ATLAS Platelet Strength Test: A New Dimension in Platelet Function Wednesday, May 22 at 1 p.m. EDT   The newest way to correlate platelet strength and size with functionality DiaPharma is excited to invite you to a webinar where we will delve into the innovative ATLAS PST…

    Read More

  • Exploring Unmet Needs in Islet Cell Transplantation and Stem Cell-Derived Islet Research

    Posted: May 6, 2024

    -Contributed by Abi Kasberg, PhD Attending my first Advanced Technologies & Treatments for Diabetes (ATTD) conference in Florence, Italy this March was a treat for the mind (and palate). Being new to the diabetes space, it was thrilling to learn about the latest insights and advancements that are being made in diabetes research to improve…

    Read More

  • Discover Technozym ADAMTS13 Activity for Your Clinical Laboratory

    Posted: April 24, 2024

    It’s Not Just Support. It’s Solutions. TECHNOZYM ADAMTS13 ACTIVITY KIT DiaPharma is pleased to offer the first in vitro diagnostic (IVD) test to receive marketing authorization by the FDA. The Technozym ADAMTS13 Activity assay is an enzyme-linked immunosorbent assay (ELISA) intended for the qualitative determination of ADAMTS13 activity in platelet poor human citrated plasma. The…

    Read More

  • Complimentary Webinar: CK18 – the Key to Unlocking Informed Decisions in MASH Drug Trials

    Posted: April 15, 2024

    It’s Not Just Support. It’s Solutions. You’re Invited: Complimentary Webinar CK18 – the Key to Unlocking Informed Decisions in MASH Drug Trials Are the Arrows Pointing in the Right Direction? CK18 Biomarkers Can Provide Insight into Your MASH Drug Candidate’s Future Success Tuesday, April 23 at 1 pm EDT When: Tuesday, April 23 at 1…

    Read More

  • Explore the Atlas PST – a New Dimension of Platelet Analysis

    Posted: March 14, 2024

    It’s Not Just Support. It’s Solutions. Balancing Platelet Strength & Function with the Stasys Atlas PST Atlas PST detects all mechanisms of platelet dysfunction in less than 3 minutes. Global assay of primary hemostatic potential Whole blood specimen for rapid analysis (< 3 minutes) Uniquely measures platelet contractile forces, aggregation, and function Reagents and agonists…

    Read More

  • Technoclone Receives US FDA Marketing Authorization for the First ADAMTS13 Activity Test

    Posted: March 5, 2024

    It’s Not Just Support. It’s Solutions. Technozym ADAMTS13 Activity granted marketing authorization by the FDA DiaPharma and Technoclone are pleased to announce the FDA De Novo classification grant and authorization to market the first in vitro diagnostic (IVD) assay for the qualitative determination of ADAMTS13 activity. The Technozym ADAMTS13 Activity assay is an enzyme-linked immunosorbent…

    Read More